510(k) Report

510(k) · Cleared

Cleared

Esperance 3+ Aspiration Catheter System

K240917510(k) TraditionalCleared Oct 1, 2024181-day reviewClass II21 CFR 870.1250

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Wallaby Medical · NRY Catheter, Thrombus Retriever

Cleared on Oct 1, 2024 as substantially equivalent to K113163 (Penumbra, Inc., 2011) after a 181-day review. Its family tree reaches back 6 generations to 2001.

Decided
Oct 1, 2024
Review
181 days
Class
Class II
Product code
NRY
Recalls
None
Predicates
1

Its longest line of descent runs back 6 generations to K003410 (2001). 8 ancestors in all, the oldest K003086 (2001). No later device cites it as a predicate yet.

  1. Root · 6 generations backK003410 Concentric Retriever, Model 90030Concentric Medical, Inc. · 2001 · Recalled
  2. 5 generations backK030476 Modified Concentric Retriever, Model 90037Concentric Medical, Inc. · 2003 · Recalled
  3. 4 generations backK033736 Merci Retriever, Models 90065, 90066Concentric Medical, Inc. · 2004
  4. 3 generations backK072718 Penumbra SystemPenumbra, Inc. · 2007 · Recalled
  5. 2 generations backK100769 Penumbra System Separator Flex (026,032,041,054), Models PSF026…Penumbra, Inc. · 2010
  6. 1 generation backK113163 Penumbra System MaxPenumbra, Inc. · 2011
  7. This deviceK240917 Esperance 3+ Aspiration Catheter SystemWallaby Medical · 2024
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−6K003410Concentric Retriever, Model 90030Concentric Medical, Inc.20011
−5K030476Modified Concentric Retriever, Model 90037Concentric Medical, Inc.20032
−4K033736Merci Retriever, Models 90065, 90066Concentric Medical, Inc.2004—
−3K072718Penumbra SystemPenumbra, Inc.20071
−2K100769Penumbra System Separator Flex (026,032,041,054), Models PSF026, PSF032…Penumbra, Inc.2010—
−1K113163Penumbra System MaxPenumbra, Inc.2011—
0 (this device)K240917Esperance 3+ Aspiration Catheter SystemWallaby Medical2024—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
200110
200910
FIG. 1 — Lineage of K240917, 2001–2024Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in NRY? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new NRY device

  1. #1 K232971 APRO 55 Catheter and Alembic Aspiration Tubingscore 18.6 · 10 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K113163Penumbra System Max
Summary page 5
…Classification: Class II Regulation Number: 21 CFR 870.1250 Product Code: NRY III. PREDICATE DEVICE Name: Penumbra System MAX Manufacturer: Penumbra, Inc. 510(k) number: K113163 IV. DEVICE DESCRIPTION Device Description: The Esperance® 3+ Aspiration Catheter is a single-use, vascular catheter consisting o…
Penumbra, Inc.2011—
†K211697Esperance Aspiration Catheter SystemWallaby Medical2021—

Also cleared against K113163: 6 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 23 years and passes through 3 companies; a new generation was cleared every 2.4 years on median.
  • 3 of the 8 ancestors have a recall of any class.
  • 6 other devices also cite its predicate K113163.

How does its category compare?

All NRY devices

NRY Catheter, Thrombus Retriever: FDA decisions, review times, recalls and adverse event reports over 20 years. 2024, this device’s year, is highlighted.

FDA decisions per year · NRY

15in 2025

2007: 52008: 22009: 22010: 12011: 22012: 42014: 42015: 62016: 52017: 32018: 112019: 72020: 62021: 92022: 32023: 82024: 82025: 152026 (partial year): 14
2007high 15 (2025) · low 0 (2013)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · NRY

129in 2025

2007: 94 days median2012: 90 days median2014: 140 days median2015: 128 days median2016: 75 days median2017: 185 days median2018: 156 days median2019: 89 days median2020: 125 days median2021: 80 days median2022: 129 days median2023: 112 days median2024: 165 days median2025: 129 days median2026 (partial year): 147 days median
2007high 185 (2017) · low 75 (2016)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · NRY

4in 2020

2010: 12013: 12017: 42020: 4, 4 Class I2026 (partial year): 2
2007high 4 (2017) · low 0 (2007)2026

Class I (4 since 2007) Class II/III not classified

Adverse event reports per year · NRY

565in 2025

2007: 132008: 182009: 572010: 2892011: 2632012: 3662013: 4052014: 4282015: 5982016: 4972017: 4322018: 4152019: 6502020: 7032021: 6882022: 5492023: 7112024: 6412025: 565
2007high 711 (2023) · low 13 (2007)2025

MAUDE reports naming product code NRY, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
2007594013
20082—018
20092—057
20101—1289
20112—0263
20124900366
20130—1405
201441400428
201561280598
20165750497
201731854432
2018111560415
20197890650
202061254 (4)703
20219800688
202231290549
202381120711
202481650641
2025151290565
2026141472—

What is it indicated for?

The Esperance 3+ Aspiration Catheter with the Wallaby Aspiration Tubing set and a compatible aspiration pump is intended for use in the revascularization of patients with acute ischemic stroke secondary to intracranial large vessel occlusive disease (within internal carotid, middle cerebral - M1 and M2 segments, basilar, and vertebral arteries) within 8 hours of symptom onset. Patients who are ineligible for intravenous tissue plasminogen activator (IV t-PA) or who fail IV t-PA therapy are candidates for treatment.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K240917: Esperance 3+ Aspiration Catheter System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K240917

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026